HU165253B - - Google Patents

Info

Publication number
HU165253B
HU165253B HUSE1666A HUSE001666A HU165253B HU 165253 B HU165253 B HU 165253B HU SE1666 A HUSE1666 A HU SE1666A HU SE001666 A HUSE001666 A HU SE001666A HU 165253 B HU165253 B HU 165253B
Authority
HU
Hungary
Application number
HUSE1666A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU165253B publication Critical patent/HU165253B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HUSE1666A 1972-02-11 1973-02-10 HU165253B (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2207421A DE2207421C3 (de) 1972-02-11 1972-02-11 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
HU165253B true HU165253B (cs) 1974-07-27

Family

ID=5836211

Family Applications (1)

Application Number Title Priority Date Filing Date
HUSE1666A HU165253B (cs) 1972-02-11 1973-02-10

Country Status (29)

Country Link
JP (1) JPS5829317B2 (cs)
KR (1) KR780000156B1 (cs)
AT (1) AT327413B (cs)
AU (1) AU467306B2 (cs)
BE (1) BE795241A (cs)
CA (1) CA997753A (cs)
CH (2) CH593995A5 (cs)
CS (1) CS193019B2 (cs)
DD (1) DD102379A5 (cs)
DE (1) DE2207421C3 (cs)
DK (1) DK131037B (cs)
EG (1) EG10914A (cs)
ES (1) ES410933A1 (cs)
FI (1) FI52225C (cs)
FR (1) FR2181719B1 (cs)
GB (1) GB1425636A (cs)
GR (1) GR63160B (cs)
HU (1) HU165253B (cs)
IE (1) IE37266B1 (cs)
IL (1) IL41506A (cs)
NL (1) NL177217C (cs)
NO (2) NO140304C (cs)
PH (1) PH9370A (cs)
PL (1) PL81084B1 (cs)
RO (1) RO73527A (cs)
SE (3) SE403781B (cs)
SU (1) SU513628A3 (cs)
YU (1) YU35035B (cs)
ZA (1) ZA73944B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007027636A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027637A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT274653B (de) * 1966-11-10 1969-09-25 Alexander Schoeller & Co Kg Stapelbarer, quaderförmiger, geschlossener Transportbehälter aus Kunststoff für feinkörnige Schüttgüter und Flüssigkeiten

Also Published As

Publication number Publication date
AU467306B2 (en) 1975-11-27
ATA112473A (de) 1975-04-15
DD102379A5 (cs) 1973-12-12
CH593995A5 (cs) 1977-12-30
NL7301974A (cs) 1973-08-14
NO140304B (no) 1979-04-30
DK131037C (cs) 1975-10-20
CS193019B2 (en) 1979-09-17
IL41506A (en) 1976-07-30
SU513628A3 (ru) 1976-05-05
GB1425636A (en) 1976-02-18
IE37266L (en) 1973-08-11
JPS4886856A (cs) 1973-11-15
CA997753A (en) 1976-09-28
AU5207673A (en) 1974-08-15
ES410933A1 (es) 1976-03-01
NO143065C (no) 1980-12-10
PL81084B1 (cs) 1975-08-30
JPS5829317B2 (ja) 1983-06-22
AT327413B (de) 1976-01-26
CH590883A5 (cs) 1977-08-31
NL177217B (nl) 1985-03-18
YU35035B (en) 1980-06-30
NO782754L (no) 1973-08-14
GR63160B (en) 1979-09-25
FI52225B (cs) 1977-03-31
IL41506A0 (en) 1973-04-30
PH9370A (en) 1975-10-22
NO140304C (no) 1979-08-08
SE403781B (sv) 1978-09-04
FR2181719A1 (cs) 1973-12-07
SE426834B (sv) 1983-02-14
DK131037B (da) 1975-05-20
KR780000156B1 (en) 1978-05-02
DE2207421C3 (de) 1981-05-07
NL177217C (nl) 1985-08-16
DE2207421A1 (de) 1973-08-16
SE7713896L (sv) 1977-12-07
DE2207421B2 (de) 1980-07-24
YU24373A (en) 1979-12-31
FI52225C (fi) 1977-07-11
SE409329B (sv) 1979-08-13
SE7514513L (sv) 1975-12-22
FR2181719B1 (cs) 1975-11-21
NO143065B (no) 1980-09-01
BE795241A (fr) 1973-08-09
EG10914A (en) 1976-09-30
IE37266B1 (en) 1977-06-08
ZA73944B (en) 1973-11-28
RO73527A (ro) 1982-02-01

Similar Documents

Publication Publication Date Title
FR2187279B3 (cs)
FI52225B (cs)
JPS4895847U (cs)
JPS4915939U (cs)
JPS4911826U (cs)
JPS4948689U (cs)
JPS4971437U (cs)
JPS4982350U (cs)
CH576991A5 (cs)
BG21763A1 (cs)
CH563177A5 (cs)
CH562747A5 (cs)
BG17922A1 (cs)
CH585385A5 (cs)
CH571105B5 (cs)
CH588722A5 (cs)
CH576549B5 (cs)
BG17866A1 (cs)
CH568307A5 (cs)
BG18223A1 (cs)
AU480295A (cs)
CH590333A5 (cs)
CH575946A5 (cs)
BG18653A1 (cs)
CH599224A5 (cs)